Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
| Size/SKU | Availability | Price |
|---|
About This Item
Empirical Formula (Hill Notation):
C10H8N2OS
CAS Number:
Molecular Weight:
204.25
MDL number:
NACRES:
NA.21
UNSPSC Code:
12352200
Assay:
≥98% (HPLC)
Form:
powder
Pricing and availability is not currently available.
Quality Segment
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
-10 to -25°C
SMILES string
O=C(C1=CC=CS1)NC2=CC=CN=C2
Application
Gliocidin may be used to investigate its effects on glioblastoma by inhibiting cell proliferation and regulating metabolic pathways. It may also be used to induce tumor cell death in glioblastoma by targeting the de novo purine synthesis pathway through the indirect inhibition of inosine monophosphate dehydrogenase 2 (IMPDH2).
Biochem/physiol Actions
Gliocidin is a potent and low-toxic BBB-permeable prodrug that targets glioblastoma by depleting guanylates via IMPDH2 inhibition; enhances effects with temozolomide. Gliocidin, a nanomolar-potent prodrug (IC50 ~9.17 nM under Nam-depleted conditions), inhibits IMPDH2, disrupting guanine nucleotide synthesis, which is crucial for tumor DNA and RNA production. Activated via the NAD+ salvage pathway into gliocidin-adenine dinucleotide (9-AD), it selectively depletes guanylate in tumor cells, leading to cell death. Gliocidin demonstrates effective blood-brain barrier penetration (brain/plasma ratio ~7.75) and significantly reduces glioblastoma growth in vivo at 50 mg/kg intraperitoneally, twice daily, without observed toxicity. Sensitivity to nicotinamide levels (IC50 increases to 35.7 μM with 1 mM Nam) underscores its pathway dependence. Combined with temozolomide (50 mg/kg/day), gliocidin′s efficacy improves through NMNAT1 upregulation, enhancing 9-AD formation and maintaining a strong safety profile. Gliocidin is known to modulate mTOR complex 1 (mTORC1) signaling and impact purine metabolism.
1 of 1
This Item | |||
|---|---|---|---|
| description ≥98% (HPLC), powder, IMPDH2 Inhibitor | description SF295 human glioblastoma cell line is a valuable model for glioblastoma research. | description clone 1E12-B6, purified immunoglobulin, buffered aqueous solution | description SF188 human glioblastoma cell line is an important cellular model for pediatric human glioblastoma. |
| form powder | form - | form buffered aqueous solution | form - |
| assay ≥98% (HPLC) | assay - | assay - | assay - |
| Quality Level 100 | Quality Level - | Quality Level 100 | Quality Level - |
| storage temp. -10 to -25°C | storage temp. - | storage temp. −20°C | storage temp. - |
| solubility DMSO: 2 mg/mL, clear | solubility - | solubility - | solubility - |
| color white to beige | color - | color - | color - |
Storage Class
11 - Combustible Solids
WGK
WGK 3
Flash Point (°F)
Not applicable
Flash Point (°C)
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.



